The Queensland Resources Council has applauded Glencore's $725,000 investment into the University of Queensland's development of a COVID-19 vaccine.
QRC Chief Executive Ian Macfarlane said the funding was another example of the sector's 'people first' response to the COVID-19 outbreak.
"Glencore's commitment to the University of Queensland will help fund the Molecular Clamp project which has moved to a phase 1 clinical trial with 120 adult volunteers," Mr Macfarlane said.
"Queensland's resources sector was one of the first to respond to the COVID-19 outbreak by strictly adhering to the advice of the State's Chief Health Officer and implementing further measures to protect our workers and the communities in which we operate.
"As the COVID-19 situation evolves here and around the world, it will be critical for our industry - like all Australians - to heed the advice from health authorities and do what we can to slow the spread of the virus.
"It is also critical as an industry we continue to devote our full attention to implementing the processes and procedures in accordance with the latest advice.
"QRC will continue to work on a full range of industry issues, but we cannot afford distractions from what is essential at this time - responding to the global pandemic that is COVID-19."
